Forecasts data is unavailable for this security.
Consensus recommendation
- 14-Dec-23
- 19-Sep-24
- 17-Oct-24
- 14-Nov-24
Select bar for recommendation details.
Recommendations | 14-Nov-24 | |
---|---|---|
Buy | 4 | |
Outperform | 6 | |
Hold | 1 | |
Sell | 0 | |
Strong Sell | 0 |
Share price forecast in USD
The 9 analysts offering 12 month price targets for Krystal Biotech Inc have a median target of 208.00, with a high estimate of 221.00 and a low estimate of 195.00. The median estimate represents a 14.10% increase from the last price of 182.29.
High | 21.2% | 221.00 |
Med | 14.1% | 208.00 |
Low | 7.0% | 195.00 |
Earnings history & estimates in USD
The next earnings announcement is expected on Feb 24, 2025.
Average growth rate | +389.78% |
Average growth rate | -66.98% |
More ▼
Revenue history & estimates in USD
Average growth rate | +118.64% |
Average growth rate | 0.00% |
More ▼